Actuate Therapeutics sees opportunity in the daunting numbers associated with metastatic pancreatic cancer: That stage of the disease accounts for approximately 80-85% of all pancreatic cancer ...

“I just can’t make it tonight. You have fun without me.” Across much of the animal kingdom, when infection strikes, social contact shuts down. A study headed by researchers at The Picower Institute ...

This academic-industry partnership reflects the need for a multidisciplinary approach to innovation in cell and gene therapy manufacturing.

EVE is a deep generative model combining evolutionary and human population data to estimate variant deleteriousness on a proteome-wide scale.

The U.S. is AstraZeneca’s largest market by sales and is also home to 19 R&D, manufacturing, and commercial sites.

Precipitation-based purification method could replace current Protein A–reliant methods, significantly reducing manufacturing costs of mAbs.

Sustainable bioprocessing boosts cyanobacterial pigment production for advanced biomedical, imaging, and commercial applications.

The U.S. Pharmacopeia has created new standards to support the emerging field of advanced cell and gene therapies.

Multiple microbial communities populate cleanrooms, regardless of grade, and aren’t detected by standard monitoring methods.

The surprising findings could improve how doctors manage type 1 diabetes and ease the significant burden that people with the condition face when using insulin alone. In their published paper in ...

Scripps Research uses advanced AI computing to speed HIV vaccine development by rapidly analyzing clinical data.